+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Drug of Abuse Testing Market Research Report by Component (Analyzers, Consumables, and Laboratory Services), Sample Type, End User, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • ID: 4896653
  • Report
  • April 2022
  • Region: Global
  • 182 Pages
  • 360iResearch™
UP TO OFF until Dec 31st 2022

FEATURED COMPANIES

  • Abbott Laboratories
  • Drgerwerk AG & Co. KGaA
  • GE Healthcare Inc.
  • Merck KGaA
  • Psychemedics Corporation
  • Siemens AG
The Global Drug of Abuse Testing Market size was estimated at USD 1,525.78 million in 2021, USD 1,632.60 million in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 7.17% to reach USD 2,312.79 million by 2027.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Drug of Abuse Testing to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Component, the market was studied across Analyzers, Consumables, Laboratory Services, and Rapid Testing Devices.
  • Based on Sample Type, the market was studied across Blood, Hair, Oral Fluids, Sweat, and Urine.
  • Based on End User, the market was studied across Criminal Justice Systems and Law Enforcement Agencies, Hospitals, Research Laboratories, and Workplace and School.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.

This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Drug of Abuse Testing market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Drug of Abuse Testing Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Drug of Abuse Testing Market, including Abbott Laboratories, Bio-Rad Laboratories, Inc., Clinical Reference Laboratory, Inc., Danaher Corporation, Drgerwerk AG & Co. KGaA, Express Diagnostics International, F. Hoffmann-La Roche Ltd, GE Healthcare Inc., LabCorp, Laboratory Corporation of America Holdings, Legacy Healthcare Services, Inc., Mayo Collaborative Services, Inc., Merck KGaA, Pfizer Inc., Precision Diagnostic Services Inc, Psychemedics Corporation, Quest Diagnostics Incorporated, Sanofi SA, Siemens AG, and Thermo Fisher Scientific.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Drug of Abuse Testing Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Drug of Abuse Testing Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Drug of Abuse Testing Market?
4. What is the competitive strategic window for opportunities in the Global Drug of Abuse Testing Market?
5. What are the technology trends and regulatory frameworks in the Global Drug of Abuse Testing Market?
6. What is the market share of the leading vendors in the Global Drug of Abuse Testing Market?
7. What modes and strategic moves are considered suitable for entering the Global Drug of Abuse Testing Market?
Frequently Asked Questions about the Global Drug of Abuse Testing Market

What is the estimated value of the Global Drug of Abuse Testing Market?

The Global Drug of Abuse Testing Market was estimated to be valued at $1525.8 Million in 2021.

What is the growth rate of the Global Drug of Abuse Testing Market?

The growth rate of the Global Drug of Abuse Testing Market is 7.1%, with an estimated value of $2312.8 Million by 2027.

What is the forecasted size of the Global Drug of Abuse Testing Market?

The Global Drug of Abuse Testing Market is estimated to be worth $2312.8 Million by 2027.

Who are the key companies in the Global Drug of Abuse Testing Market?

Key companies in the Global Drug of Abuse Testing Market include Abbott Laboratories, Bio, Rad Laboratories, Inc., Clinical Reference Laboratory, Inc., Danaher Corporation, Drgerwerk AG & Co. KGaA, Express Diagnostics International, F. Hoffmann and GE Healthcare Inc..
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • Drgerwerk AG & Co. KGaA
  • GE Healthcare Inc.
  • Merck KGaA
  • Psychemedics Corporation
  • Siemens AG

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing demand for drug abuse treatment
5.1.1.2. Stringent law mandating alcohol and drug testing
5.1.1.3. Increasing drug-related mortality rate and government initiative
5.1.2. Restraints
5.1.2.1. Drug testing is recognized as a violation of privacy rights in some countries
5.1.3. Opportunities
5.1.3.1. Introduction to innovative and user-friendly disposable products
5.1.3.2. Technological advancements in drug testing
5.1.4. Challenges
5.1.4.1. Limited awareness and breach of privacy rights
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of 2022 Russia Ukraine Conflict
6. Drug of Abuse Testing Market, by Component
6.1. Introduction
6.2. Analyzers
6.3. Consumables
6.4. Laboratory Services
6.5. Rapid Testing Devices
7. Drug of Abuse Testing Market, by Sample Type
7.1. Introduction
7.2. Blood
7.3. Hair
7.4. Oral Fluids
7.5. Sweat
7.6. Urine
8. Drug of Abuse Testing Market, by End User
8.1. Introduction
8.2. Criminal Justice Systems and Law Enforcement Agencies
8.3. Hospitals
8.4. Research Laboratories
8.5. Workplace and School
9. Americas Drug of Abuse Testing Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Drug of Abuse Testing Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
11. Europe, Middle East & Africa Drug of Abuse Testing Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. Abbott Laboratories
13.2. Bio-Rad Laboratories, Inc.
13.3. Clinical Reference Laboratory, Inc.
13.4. Danaher Corporation
13.5. Drgerwerk AG & Co. KGaA
13.6. Express Diagnostics International
13.7. F. Hoffmann-La Roche Ltd
13.8. GE Healthcare Inc.
13.9. LabCorp
13.10. Laboratory Corporation of America Holdings
13.11. Legacy Healthcare Services, Inc.
13.12. Mayo Collaborative Services, Inc.
13.13. Merck KGaA
13.14. Pfizer Inc.
13.15. Precision Diagnostic Services Inc
13.16. Psychemedics Corporation
13.17. Quest Diagnostics Incorporated
13.18. Sanofi SA
13.19. Siemens AG
13.20. Thermo Fisher Scientific
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL DRUG OF ABUSE TESTING MARKET: DYNAMICS
FIGURE 2. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2021 VS 2027 (%)
FIGURE 3. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2021 VS 2027 (USD MILLION)
FIGURE 4. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2027
FIGURE 5. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY ANALYZERS, 2019-2027 (USD MILLION)
FIGURE 6. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY ANALYZERS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 7. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY CONSUMABLES, 2019-2027 (USD MILLION)
FIGURE 8. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY CONSUMABLES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 9. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY LABORATORY SERVICES, 2019-2027 (USD MILLION)
FIGURE 10. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY LABORATORY SERVICES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 11. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2019-2027 (USD MILLION)
FIGURE 12. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY RAPID TESTING DEVICES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 13. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2021 VS 2027 (%)
FIGURE 14. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2021 VS 2027 (USD MILLION)
FIGURE 15. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2027
FIGURE 16. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY BLOOD, 2019-2027 (USD MILLION)
FIGURE 17. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY BLOOD, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 18. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY HAIR, 2019-2027 (USD MILLION)
FIGURE 19. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY HAIR, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 20. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY ORAL FLUIDS, 2019-2027 (USD MILLION)
FIGURE 21. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY ORAL FLUIDS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 22. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY SWEAT, 2019-2027 (USD MILLION)
FIGURE 23. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY SWEAT, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 24. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY URINE, 2019-2027 (USD MILLION)
FIGURE 25. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY URINE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 26. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2021 VS 2027 (%)
FIGURE 27. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2021 VS 2027 (USD MILLION)
FIGURE 28. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2027
FIGURE 29. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY CRIMINAL JUSTICE SYSTEMS AND LAW ENFORCEMENT AGENCIES, 2019-2027 (USD MILLION)
FIGURE 30. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY CRIMINAL JUSTICE SYSTEMS AND LAW ENFORCEMENT AGENCIES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 31. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY HOSPITALS, 2019-2027 (USD MILLION)
FIGURE 32. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 33. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY RESEARCH LABORATORIES, 2019-2027 (USD MILLION)
FIGURE 34. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 35. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY WORKPLACE AND SCHOOL, 2019-2027 (USD MILLION)
FIGURE 36. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY WORKPLACE AND SCHOOL, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 37. AMERICAS DRUG OF ABUSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 38. ARGENTINA DRUG OF ABUSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 39. BRAZIL DRUG OF ABUSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 40. CANADA DRUG OF ABUSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 41. MEXICO DRUG OF ABUSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 42. UNITED STATES DRUG OF ABUSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 43. ASIA-PACIFIC DRUG OF ABUSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 44. AUSTRALIA DRUG OF ABUSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 45. CHINA DRUG OF ABUSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 46. INDIA DRUG OF ABUSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 47. INDONESIA DRUG OF ABUSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 48. JAPAN DRUG OF ABUSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 49. MALAYSIA DRUG OF ABUSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 50. PHILIPPINES DRUG OF ABUSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 51. SINGAPORE DRUG OF ABUSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 52. SOUTH KOREA DRUG OF ABUSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 53. TAIWAN DRUG OF ABUSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 54. THAILAND DRUG OF ABUSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 55. EUROPE, MIDDLE EAST & AFRICA DRUG OF ABUSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 56. FRANCE DRUG OF ABUSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 57. GERMANY DRUG OF ABUSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 58. ITALY DRUG OF ABUSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 59. NETHERLANDS DRUG OF ABUSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 60. QATAR DRUG OF ABUSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 61. RUSSIA DRUG OF ABUSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 62. SAUDI ARABIA DRUG OF ABUSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 63. SOUTH AFRICA DRUG OF ABUSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 64. SPAIN DRUG OF ABUSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 65. UNITED ARAB EMIRATES DRUG OF ABUSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 66. UNITED KINGDOM DRUG OF ABUSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 67. GLOBAL DRUG OF ABUSE TESTING MARKET: FPNV POSITIONING MATRIX
FIGURE 68. GLOBAL DRUG OF ABUSE TESTING MARKET: SHARE, BY KEY PLAYER, 2021
FIGURE 69. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL DRUG OF ABUSE TESTING MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL DRUG OF ABUSE TESTING MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2019-2027 (USD MILLION)
TABLE 4. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY ANALYZERS, BY REGION, 2019-2027 (USD MILLION)
TABLE 5. AMERICAS DRUG OF ABUSE TESTING MARKET SIZE, BY ANALYZERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 6. UNITED STATES DRUG OF ABUSE TESTING MARKET SIZE, BY ANALYZERS, BY STATE, 2019-2027 (USD MILLION)
TABLE 7. ASIA-PACIFIC DRUG OF ABUSE TESTING MARKET SIZE, BY ANALYZERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 8. EUROPE, MIDDLE EAST & AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY ANALYZERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 9. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY CONSUMABLES, BY REGION, 2019-2027 (USD MILLION)
TABLE 10. AMERICAS DRUG OF ABUSE TESTING MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 11. UNITED STATES DRUG OF ABUSE TESTING MARKET SIZE, BY CONSUMABLES, BY STATE, 2019-2027 (USD MILLION)
TABLE 12. ASIA-PACIFIC DRUG OF ABUSE TESTING MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 13. EUROPE, MIDDLE EAST & AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 14. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY LABORATORY SERVICES, BY REGION, 2019-2027 (USD MILLION)
TABLE 15. AMERICAS DRUG OF ABUSE TESTING MARKET SIZE, BY LABORATORY SERVICES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 16. UNITED STATES DRUG OF ABUSE TESTING MARKET SIZE, BY LABORATORY SERVICES, BY STATE, 2019-2027 (USD MILLION)
TABLE 17. ASIA-PACIFIC DRUG OF ABUSE TESTING MARKET SIZE, BY LABORATORY SERVICES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 18. EUROPE, MIDDLE EAST & AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY LABORATORY SERVICES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 19. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY RAPID TESTING DEVICES, BY REGION, 2019-2027 (USD MILLION)
TABLE 20. AMERICAS DRUG OF ABUSE TESTING MARKET SIZE, BY RAPID TESTING DEVICES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 21. UNITED STATES DRUG OF ABUSE TESTING MARKET SIZE, BY RAPID TESTING DEVICES, BY STATE, 2019-2027 (USD MILLION)
TABLE 22. ASIA-PACIFIC DRUG OF ABUSE TESTING MARKET SIZE, BY RAPID TESTING DEVICES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 23. EUROPE, MIDDLE EAST & AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY RAPID TESTING DEVICES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 24. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2019-2027 (USD MILLION)
TABLE 25. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY BLOOD, BY REGION, 2019-2027 (USD MILLION)
TABLE 26. AMERICAS DRUG OF ABUSE TESTING MARKET SIZE, BY BLOOD, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 27. UNITED STATES DRUG OF ABUSE TESTING MARKET SIZE, BY BLOOD, BY STATE, 2019-2027 (USD MILLION)
TABLE 28. ASIA-PACIFIC DRUG OF ABUSE TESTING MARKET SIZE, BY BLOOD, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 29. EUROPE, MIDDLE EAST & AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY BLOOD, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 30. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY HAIR, BY REGION, 2019-2027 (USD MILLION)
TABLE 31. AMERICAS DRUG OF ABUSE TESTING MARKET SIZE, BY HAIR, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 32. UNITED STATES DRUG OF ABUSE TESTING MARKET SIZE, BY HAIR, BY STATE, 2019-2027 (USD MILLION)
TABLE 33. ASIA-PACIFIC DRUG OF ABUSE TESTING MARKET SIZE, BY HAIR, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 34. EUROPE, MIDDLE EAST & AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY HAIR, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 35. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY ORAL FLUIDS, BY REGION, 2019-2027 (USD MILLION)
TABLE 36. AMERICAS DRUG OF ABUSE TESTING MARKET SIZE, BY ORAL FLUIDS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 37. UNITED STATES DRUG OF ABUSE TESTING MARKET SIZE, BY ORAL FLUIDS, BY STATE, 2019-2027 (USD MILLION)
TABLE 38. ASIA-PACIFIC DRUG OF ABUSE TESTING MARKET SIZE, BY ORAL FLUIDS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 39. EUROPE, MIDDLE EAST & AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY ORAL FLUIDS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 40. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY SWEAT, BY REGION, 2019-2027 (USD MILLION)
TABLE 41. AMERICAS DRUG OF ABUSE TESTING MARKET SIZE, BY SWEAT, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 42. UNITED STATES DRUG OF ABUSE TESTING MARKET SIZE, BY SWEAT, BY STATE, 2019-2027 (USD MILLION)
TABLE 43. ASIA-PACIFIC DRUG OF ABUSE TESTING MARKET SIZE, BY SWEAT, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 44. EUROPE, MIDDLE EAST & AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY SWEAT, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 45. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY URINE, BY REGION, 2019-2027 (USD MILLION)
TABLE 46. AMERICAS DRUG OF ABUSE TESTING MARKET SIZE, BY URINE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 47. UNITED STATES DRUG OF ABUSE TESTING MARKET SIZE, BY URINE, BY STATE, 2019-2027 (USD MILLION)
TABLE 48. ASIA-PACIFIC DRUG OF ABUSE TESTING MARKET SIZE, BY URINE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 49. EUROPE, MIDDLE EAST & AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY URINE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 50. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 51. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY CRIMINAL JUSTICE SYSTEMS AND LAW ENFORCEMENT AGENCIES, BY REGION, 2019-2027 (USD MILLION)
TABLE 52. AMERICAS DRUG OF ABUSE TESTING MARKET SIZE, BY CRIMINAL JUSTICE SYSTEMS AND LAW ENFORCEMENT AGENCIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 53. UNITED STATES DRUG OF ABUSE TESTING MARKET SIZE, BY CRIMINAL JUSTICE SYSTEMS AND LAW ENFORCEMENT AGENCIES, BY STATE, 2019-2027 (USD MILLION)
TABLE 54. ASIA-PACIFIC DRUG OF ABUSE TESTING MARKET SIZE, BY CRIMINAL JUSTICE SYSTEMS AND LAW ENFORCEMENT AGENCIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 55. EUROPE, MIDDLE EAST & AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY CRIMINAL JUSTICE SYSTEMS AND LAW ENFORCEMENT AGENCIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 56. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2019-2027 (USD MILLION)
TABLE 57. AMERICAS DRUG OF ABUSE TESTING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 58. UNITED STATES DRUG OF ABUSE TESTING MARKET SIZE, BY HOSPITALS, BY STATE, 2019-2027 (USD MILLION)
TABLE 59. ASIA-PACIFIC DRUG OF ABUSE TESTING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 60. EUROPE, MIDDLE EAST & AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 61. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2019-2027 (USD MILLION)
TABLE 62. AMERICAS DRUG OF ABUSE TESTING MARKET SIZE, BY RESEARCH LABORATORIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 63. UNITED STATES DRUG OF ABUSE TESTING MARKET SIZE, BY RESEARCH LABORATORIES, BY STATE, 2019-2027 (USD MILLION)
TABLE 64. ASIA-PACIFIC DRUG OF ABUSE TESTING MARKET SIZE, BY RESEARCH LABORATORIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 65. EUROPE, MIDDLE EAST & AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY RESEARCH LABORATORIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 66. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY WORKPLACE AND SCHOOL, BY REGION, 2019-2027 (USD MILLION)
TABLE 67. AMERICAS DRUG OF ABUSE TESTING MARKET SIZE, BY WORKPLACE AND SCHOOL, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 68. UNITED STATES DRUG OF ABUSE TESTING MARKET SIZE, BY WORKPLACE AND SCHOOL, BY STATE, 2019-2027 (USD MILLION)
TABLE 69. ASIA-PACIFIC DRUG OF ABUSE TESTING MARKET SIZE, BY WORKPLACE AND SCHOOL, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 70. EUROPE, MIDDLE EAST & AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY WORKPLACE AND SCHOOL, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 71. AMERICAS DRUG OF ABUSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 72. ARGENTINA DRUG OF ABUSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 73. BRAZIL DRUG OF ABUSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 74. CANADA DRUG OF ABUSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 75. MEXICO DRUG OF ABUSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 76. UNITED STATES DRUG OF ABUSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 77. ASIA-PACIFIC DRUG OF ABUSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 78. AUSTRALIA DRUG OF ABUSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 79. CHINA DRUG OF ABUSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 80. INDIA DRUG OF ABUSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 81. INDONESIA DRUG OF ABUSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 82. JAPAN DRUG OF ABUSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 83. MALAYSIA DRUG OF ABUSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 84. PHILIPPINES DRUG OF ABUSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 85. SINGAPORE DRUG OF ABUSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 86. SOUTH KOREA DRUG OF ABUSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 87. TAIWAN DRUG OF ABUSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 88. THAILAND DRUG OF ABUSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 89. EUROPE, MIDDLE EAST & AFRICA DRUG OF ABUSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 90. FRANCE DRUG OF ABUSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 91. GERMANY DRUG OF ABUSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 92. ITALY DRUG OF ABUSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 93. NETHERLANDS DRUG OF ABUSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 94. QATAR DRUG OF ABUSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 95. RUSSIA DRUG OF ABUSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 96. SAUDI ARABIA DRUG OF ABUSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 97. SOUTH AFRICA DRUG OF ABUSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 98. SPAIN DRUG OF ABUSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 99. UNITED ARAB EMIRATES DRUG OF ABUSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 100. UNITED KINGDOM DRUG OF ABUSE TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 101. GLOBAL DRUG OF ABUSE TESTING MARKET: SCORES
TABLE 102. GLOBAL DRUG OF ABUSE TESTING MARKET: BUSINESS STRATEGY
TABLE 103. GLOBAL DRUG OF ABUSE TESTING MARKET: PRODUCT SATISFACTION
TABLE 104. GLOBAL DRUG OF ABUSE TESTING MARKET: RANKING
TABLE 105. GLOBAL DRUG OF ABUSE TESTING MARKET: SHARE, BY KEY PLAYER, 2021
TABLE 106. GLOBAL DRUG OF ABUSE TESTING MARKET: MERGER & ACQUISITION
TABLE 107. GLOBAL DRUG OF ABUSE TESTING MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 108. GLOBAL DRUG OF ABUSE TESTING MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 109. GLOBAL DRUG OF ABUSE TESTING MARKET: INVESTMENT & FUNDING
TABLE 110. GLOBAL DRUG OF ABUSE TESTING MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 111. GLOBAL DRUG OF ABUSE TESTING MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • Abbott Laboratories
  • Bio-Rad Laboratories, Inc.
  • Clinical Reference Laboratory, Inc.
  • Danaher Corporation
  • Drgerwerk AG & Co. KGaA
  • Express Diagnostics International
  • F. Hoffmann-La Roche Ltd
  • GE Healthcare Inc.
  • LabCorp
  • Laboratory Corporation of America Holdings
  • Legacy Healthcare Services, Inc.
  • Mayo Collaborative Services, Inc.
  • Merck KGaA
  • Pfizer Inc.
  • Precision Diagnostic Services Inc
  • Psychemedics Corporation
  • Quest Diagnostics Incorporated
  • Sanofi SA
  • Siemens AG
  • Thermo Fisher Scientific
Note: Product cover images may vary from those shown

Loading
LOADING...